广东大冢制药有限公司

ABOUT US

Guangdong Otsuka Pharmaceutical Co., Ltd was established in 1993, which is a joint venture modern pharmaceutical company co-invested by China Otsuka Pharmaceutical Co., Ltd and Japan Otsuka Pharmaceutical

1993

Was founded in

2840US$

Registered capital

COMPANY CULTURE

imgboxbg
 广东大冢制药有限公司

Corporate Vision

Become a leader in the field of liquid therapy and full-cycle nutrition in China

imgboxbg
 广东大冢制药有限公司

Our Mission

Caring for life, providing high-quality products and services for human health

imgboxbg
 广东大冢制药有限公司

Enterprise Spirit

Self-improvement and virtue, openness and innovation, win-win cooperation Core values: quality is life

imgboxbg
 广东大冢制药有限公司

Corporate Purposes

Scientific development, giving back to shareholders, benefiting employees and contributing to society

imgboxbg
 广东大冢制药有限公司

Core Value

Implement the work quality, management quality and product quality into the whole process of improving the company's quality management.

imgboxbg
 广东大冢制药有限公司

Employee Code of Conduct

Law-abiding, loyalty and dedication, dedication, diligent study, honesty and trustworthiness, unity and cooperation

PRODUCTS

MERCHANTS

Implement work quality, management quality, and product quality into the whole process of improving the company's quality management.

NEWS

Committed to providing patients with more and broader products and services,

users are welcome to come to consult

Environmental Protection Test Report for the First Quarter of 2021

Environmental Protection Test Report for the First Quarter of 2021

Environmental Protection Test Report for the First Quarter of 2021
Environmental Protection Test Report for the Second Quarter of 2021

Environmental Protection Test Report for the Second Quarter of 2021

Environmental Protection Test Report for the Second Quarter of 2021
2020 New Drug Registration Clinical Trial Status Report Released

2020 New Drug Registration Clinical Trial Status Report Released

A few days ago, the Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Status of Clinical Trials of New Drug Registration in China (2020)" (hereinafter referred to as the "Report"). Based on the registration information of the 2020 drug clinical trial registration and information publicity platform, the "Report" is the first to conduct a comprehensive summary and analysis of the current status of new drug registration clinical trials in my country.

Guangdong Otsuka Pharmaceutical Co., Ltd.

Hotline:

0757-28305861

High-tech Industrial Park, Ronggui Street, Shunde District, Foshan City, Guangdong Province, China

Copyright © 2021 Guangdong Otsuka Pharmaceutical Co., Ltd.           粤ICP备09154721号            Powered by www.300.cn